HSP90AA1 and central nervous system cancer: Moreover, inhibition of HSP90 by onalespib disrupted cell signaling of several HSP90 client proteins and decreased proliferation, migration, and angiogenesis of glioma cells lines and patient-derived glioma-initiating cells [147].